1997
|
Sign up to set email alerts
p53 Regulates Apoptosis in Human Retinoblastoma
Search citation statements
Order By: Relevance
Paper Sections
Select...
54
9
6
2
Citation Types
4
41
1
0
Year Published
Range
1996
19962025
2025Publication Types
Select...
45
21
Relationship
0
66
Authors
Journals
Cited by 66 publications
(46 citation statements)
References 24 publications
4
41
1
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the present study, human retinoblastoma cells demonstrated a variable immunoreactivity against the anti-p53 antibody (FL-393), showing a similar trend with the results of a previous study using the DO-1 monoclonal antibody (9). When comparing the distribution of p53 immunopositivity with DAPI nuclear counterstaining, the p53 protein in retinoblastoma cells was mainly nuclear, with some cytoplasmic localization.…”
Section: Results
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the present study, human retinoblastoma cells demonstrated a variable immunoreactivity against the anti-p53 antibody (FL-393), showing a similar trend with the results of a previous study using the DO-1 monoclonal antibody (9). When comparing the distribution of p53 immunopositivity with DAPI nuclear counterstaining, the p53 protein in retinoblastoma cells was mainly nuclear, with some cytoplasmic localization.…”
Section: Results
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Nork et al. found abundant TUNEL‐positive cells especially at the interphase of the necrotic and viable tumour regions 13 . The same feature was observed in our study.…”
Section: Discussion
supporting
confidence: 92%
“…Apoptosis was reported to be more prevalent in undifferentiated Rb 7,13 . Similarly, we found a slightly higher rate of apoptosis in our undifferentiated cases than differentiated ones (3.1 and 2.7%, respectively), the difference being statistically not significant.…”
Section: Discussion
contrasting
confidence: 49%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Retinoblastoma cells were negative for BCL-2, the antidote to PCD; perivascular glial cells and scattered astrocytes within the tumour islands only were positive for BCL-2. This absence of BCL-2, together with the extensive apoptosis observed in the majority of the retinoblastomas, would tend to support the suggestion of Nork et al , that apoptosis in retinoblastoma is most likely p53 induced 49. Our findings, however, contrast with those of Yuge et al , who described weak positivity for BCL-2 in all retinoblastoma cells 57.…”
Section: Discussion
supporting
confidence: 83%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the present study, human retinoblastoma cells demonstrated a variable immunoreactivity against the anti-p53 antibody (FL-393), showing a similar trend with the results of a previous study using the DO-1 monoclonal antibody (9). When comparing the distribution of p53 immunopositivity with DAPI nuclear counterstaining, the p53 protein in retinoblastoma cells was mainly nuclear, with some cytoplasmic localization.…”
Section: Results
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Nork et al. found abundant TUNEL‐positive cells especially at the interphase of the necrotic and viable tumour regions 13 . The same feature was observed in our study.…”
Section: Discussion
supporting
confidence: 92%
“…Apoptosis was reported to be more prevalent in undifferentiated Rb 7,13 . Similarly, we found a slightly higher rate of apoptosis in our undifferentiated cases than differentiated ones (3.1 and 2.7%, respectively), the difference being statistically not significant.…”
Section: Discussion
contrasting
confidence: 49%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Retinoblastoma cells were negative for BCL-2, the antidote to PCD; perivascular glial cells and scattered astrocytes within the tumour islands only were positive for BCL-2. This absence of BCL-2, together with the extensive apoptosis observed in the majority of the retinoblastomas, would tend to support the suggestion of Nork et al , that apoptosis in retinoblastoma is most likely p53 induced 49. Our findings, however, contrast with those of Yuge et al , who described weak positivity for BCL-2 in all retinoblastoma cells 57.…”
Section: Discussion
supporting
confidence: 83%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the present study, human retinoblastoma cells demonstrated a variable immunoreactivity against the anti-p53 antibody (FL-393), showing a similar trend with the results of a previous study using the DO-1 monoclonal antibody (9). When comparing the distribution of p53 immunopositivity with DAPI nuclear counterstaining, the p53 protein in retinoblastoma cells was mainly nuclear, with some cytoplasmic localization.…”
Section: Results
supporting
confidence: 88%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Nork et al. found abundant TUNEL‐positive cells especially at the interphase of the necrotic and viable tumour regions 13 . The same feature was observed in our study.…”
Section: Discussion
supporting
confidence: 92%
“…Apoptosis was reported to be more prevalent in undifferentiated Rb 7,13 . Similarly, we found a slightly higher rate of apoptosis in our undifferentiated cases than differentiated ones (3.1 and 2.7%, respectively), the difference being statistically not significant.…”
Section: Discussion
contrasting
confidence: 49%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Retinoblastoma cells were negative for BCL-2, the antidote to PCD; perivascular glial cells and scattered astrocytes within the tumour islands only were positive for BCL-2. This absence of BCL-2, together with the extensive apoptosis observed in the majority of the retinoblastomas, would tend to support the suggestion of Nork et al , that apoptosis in retinoblastoma is most likely p53 induced 49. Our findings, however, contrast with those of Yuge et al , who described weak positivity for BCL-2 in all retinoblastoma cells 57.…”
Section: Discussion
supporting
confidence: 83%